Shiseido Company, Limited (TYO:4911)
| Market Cap | 1.30T |
| Revenue (ttm) | 969.99B |
| Net Income (ttm) | -40.68B |
| Shares Out | 399.54M |
| EPS (ttm) | -101.83 |
| PE Ratio | n/a |
| Forward PE | 31.50 |
| Dividend | 60.00 (1.91%) |
| Ex-Dividend Date | Jun 29, 2026 |
| Volume | 2,318,900 |
| Average Volume | 2,453,875 |
| Open | 3,200.00 |
| Previous Close | 3,138.00 |
| Day's Range | 3,186.00 - 3,255.00 |
| 52-Week Range | 2,135.00 - 3,535.00 |
| Beta | 0.55 |
| RSI | 53.81 |
| Earnings Date | May 12, 2026 |
About Shiseido Company
Shiseido Company, Limited produces and sells in Japan and internationally. It offers fragrances, skincare, and makeup products through retail channels. The company also engages in the restaurant and food businesses; and operates beauty salons. In addition, it operates and supports SABFA, a professional hair makeup training school. Further, the company manages childcare facilities. It serves its products under the BAUM, BENEFIQUE, Clé de Peau Beauté, Dr. Dennis Gross Skincare, Drunk Elephant, EFFECTIM, Gallinée, INOUI, IPSA, ISSEY MIYAKE PARFUMS... [Read more]
Financial Performance
In 2025, Shiseido Company's revenue was 969.99 billion, a decrease of -2.08% compared to the previous year's 990.59 billion. Losses were -40.68 billion, 276.2% more than in 2024.
Financial StatementsNews
L'Oréal-Backed Chando Files For Hong Kong IPO
The company is China's latest cosmetics brand to file for a Hong Kong IPO, boasting ‘unicorn' status with a $1 billion valuation after a recent funding whose investors included L'Oréal image credit: B...
Shiseido Company Earnings Call Transcript: Q4 2025
FY 2025 saw core operating profit and free cash flow exceed targets, driven by structure reforms and cost management, despite revenue decline. FY 2026 targets higher margins and capital efficiency, with continued investment in innovation and brand growth amid market volatility.
Shiseido Company Earnings Call Transcript: Q3 2025
Q3 marked a return to positive sales growth, driven by structural reforms and cost discipline, despite a net loss from non-recurring items. The company maintains its core operating profit target and expects strong free cash flow, with a focus on innovation, brand growth, and global expansion.
Shiseido Company Earnings Call Transcript: Q2 2025
Structural reforms and cost reductions led to improved profitability in H1 2025, with core operating profit exceeding expectations despite a 6% sales decline. Risks remain in Japan inbound and Americas, but cost management and strong brand performance support the unchanged full-year outlook.
Shiseido Company Transcript: Investor Day 2025
ELIXIR and ANESSA are driving strong growth and profitability through strategic product focus, channel expansion, and innovation, with ELIXIR outpacing company-wide growth and ANESSA strengthening its leadership in Asia. Both brands emphasize sustainability and social value creation.
Shiseido Company Earnings Call Transcript: Q4 2024
Core operating profit exceeded forecasts in 2024, driven by strong performance in Japan and Europe, while China and travel retail remained challenging but showed signs of stabilization. Structural reforms and cost reductions boosted profitability, and 2025 guidance targets further growth, especially in Japan and the Americas.
Shiseido Company Earnings Call Transcript: Q3 2024
Q3 2024 saw profit improvement in Japan offset by steep declines in travel retail and China, leading to a downward revision of full-year profit forecasts. Structural reforms and cost controls are ongoing, with Japan's strong performance supporting overall results.
Shiseido Company Earnings Call Transcript: Q2 2024
First half 2024 saw a 1% year-over-year sales decline and a significant drop in core operating profit, mainly due to weakness in Travel Retail and China, despite strong growth in Japan and EMEA. Cost reduction and restructuring efforts are on track, with a focus on core brands and digital expansion for recovery.
Shiseido Company Earnings Call Transcript: Q1 2024
Boeing, Estée Lauder, and 5 Other Stocks for a Very Confusing Market
Portfolio managers at this week's Morningstar Investment Conference named stocks within aerospace like Boeing, General Electric as well as luxury goods maker like LVMH.
Shiseido Refocuses On Luxury After $1.5 Billion Spin-Off To CVC Capital
The Japanese beauty house will retain a 35% share in a new entity, but is now freed up to pursue the prestige end of the market which it considers more strategic.
Beauty Sector Looks Promising Amid COVID-19
COVID-19 stay-at-home orders forced the closure of non-essential businesses, hurting the supply chain and travel-focused industries the most.
These Large-Cap Stocks Showed Strong Performance
Shareholders of Zoetis Inc (NYSE:ZTS), Shiseido Company Limited (SSDOY) and TransUnion (NYSE:TRU) have reason to be satisfied as their holdings have delivered large gains over the past several years, ...